DR IA GILKAR & PARTNERS — All Prescriptions & Medications — Page 2
Practice Code: B83622 | BRADFORD, BD8 9LB
Showing results 51-100 of 465
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Prednisolone | 470 | 12.7K | £494 | -41.2% ▼ |
| Solifenacin | 453 | 8,606 | £352 | -5.1% ▼ |
| Flucloxacillin sodium | 437 | 19.0K | £1.1K | -2.8% ▼ |
| Indapamide | 431 | 11.8K | £387 | -50.0% ▼ |
| Diazepam | 425 | 2,244 | £90 | -14.7% ▼ |
| Lisinopril | 419 | 11.9K | £713 | -61.8% ▼ |
| 417 | 233.0K | £3.4K | -57.6% ▼ | |
| Fexofenadine hydrochloride | 411 | 14.6K | £643 | -51.7% ▼ |
| Spironolactone | 409 | 4,758 | £548 | -24.1% ▼ |
| Pantoprazole | 387 | 12.4K | £593 | +40.8% ▲ |
| Pregabalin | 383 | 19.5K | £1.3K | -69.5% ▼ |
| Nitrofurantoin | 378 | 6,209 | £4.1K | -20.8% ▼ |
| 373 | 153.4K | £2.9K | +41.4% ▲ | |
| Hydrocortisone | 369 | 11.2K | £1.8K | -17.7% ▼ |
| Edoxaban | 368 | 4,550 | £7.6K | -47.5% ▼ |
| Dapagliflozin | 354 | 5,411 | £6.7K | -71.7% ▼ |
| Tamsulosin hydrochloride | 352 | 10.8K | £1.2K | -74.0% ▼ |
| Hyoscine butylbromide | 346 | 9,582 | £686 | +48.5% ▲ |
| Morphine sulfate | 343 | 44.1K | £1.4K | -47.7% ▼ |
| Fluoxetine hydrochloride | 333 | 13.8K | £495 | -67.2% ▼ |
| Levetiracetam | 314 | 38.0K | £5.6K | -31.4% ▼ |
| Sitagliptin | 308 | 5,679 | £351 | -21.0% ▼ |
| Cyanocobalamin | 306 | 11.5K | £1.8K | -13.3% ▼ |
| Zopiclone | 301 | 4,167 | £186 | -45.6% ▼ |
| Lamotrigine | 296 | 15.8K | £2.9K | -49.9% ▼ |
| Docusate sodium | 294 | 5,724 | £435 | -20.7% ▼ |
| Mirabegron | 287 | 5,289 | £4.9K | -28.6% ▼ |
| Betahistine hydrochloride | 276 | 20.7K | £793 | +15.6% ▲ |
| Carbocisteine | 271 | 39.0K | £1.3K | -49.2% ▼ |
| Atenolol | 269 | 8,436 | £199 | -55.4% ▼ |
| Rosuvastatin calcium | 251 | 4,612 | £155 | -72.0% ▼ |
| Mebeverine hydrochloride | 250 | 11.4K | £1.4K | -19.5% ▼ |
| Lactulose | 249 | 104.9K | £1.1K | -24.4% ▼ |
| Loratadine | 240 | 5,745 | £143 | +14.9% ▲ |
| Escitalopram | 240 | 2,751 | £173 | -15.7% ▼ |
| Bumetanide | 237 | 5,255 | £851 | -13.0% ▼ |
| Pioglitazone hydrochloride | 236 | 7,182 | £579 | +166.9% ▲ |
| Apixaban | 235 | 4,508 | £462 | -82.3% ▼ |
| Allopurinol | 233 | 6,090 | £148 | -77.4% ▼ |
| Eplerenone | 228 | 2,163 | £314 | -14.0% ▼ |
| Risedronate sodium | 228 | 964 | £255 | +88.0% ▲ |
| Venlafaxine | 219 | 4,995 | £987 | -74.1% ▼ |
| Clarithromycin | 218 | 4,102 | £1.0K | -11.2% ▼ |
| Glyceryl trinitrate | 217 | 217 | £531 | -8.3% ▼ |
| 214 | 229 | £284 | -2.9% ▼ | |
| 208 | 1,660 | £447 | -0.5% vs avg | |
| Biphasic insulin lispro | 206 | 2,676 | £16.6K | +379.8% ▲ |
| Umeclidinium bromide/vilanterol | 204 | 211 | £6.5K | +4.6% ▲ |
| Budesonide | 201 | 1,085 | £7.1K | -62.9% ▼ |
| Rivaroxaban | 200 | 4,291 | £2.7K | -67.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.